Visum Pharmaceutical

  • Visum Pharmaceutical
About Visum Pharmaceutical

Visum pharmaceutical is a US FDA & NMPA approved manufactuer located in Hainan, China, specialized in producing high-end oral solids, half- solids, liquids and high-activity pharmaceutical final dosages. Two generic drugs have been launched in US and are looking for global distributors.We also provide CDMO/CMO services for international partners with high standards.

Certifications
  • CN
  • 2022
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info

Products from Visum Pharmaceutical (7)

  • Analytical Method Develpment and Validation

    Product Analytical Method Develpment and Validation

    Providing Analytical method development, validation and stability study from Phase I-III to commercial prodcution and registration.
  • CDMO- Finished Dosage Forms

    Product CDMO- Finished Dosage Forms

    Contract Development and Manufacturing Services for Various Dosage Forms:
    • Tablets
    • Capsules
    • Granules/Powder for OS
    • Oral Solutions
    • Drops
    • Ointment
    • Cream
    • Gel
  • Clinical Supply Manufacturing

    Product Clinical Supply Manufacturing

    NCEs
    • Phase I-III formulation process development and clinical supply manufacturing
    Generic drugs
    • BE sample manufacturing
    • Process Optimization
  • Commercial Manufacturing

    Product Commercial Manufacturing

    Standards:
    • US, EU, China, WHO
    Commercial Scales
    • Tablets: 3 billion/year
    • Capsules: 500 million/year
    • Oral solution: 100 million/year
    • Ointment: 50 million/year
    • Granules: 300 million/year
  • Formulation Development

    Product Formulation Development

    NCEs
    • Phase I-III formulation and development
    Generic Drugs
    • Pharmaceutical, analytical method development and process study
  • Metoprolol Succinate Extended-Release Tablets

    Product Metoprolol Succinate Extended-Release Tablets

    Metoprolol Succinate Extended-Release Tablets is a beta 1-selevitve adrenoceptor blocking agent, which can  reduce heart rate, myocardial contractility, blood pressure, antagonize the toxicity of catecholamine adreneric transmitters, and has good cardiovascular protection. It is widely used in cardiovasc...
  • Paroxetine Extended-Release Tablets

    Product Paroxetine Extended-Release Tablets

    For the treatment of Major Depressive Disorder (MDD), Panic Disorder (PD), Social Anxiety Disorder (SAD) and Premenstrual Dysphoric Disorder (PMDD).